about
High prevalence of medication use in professional football tournaments including the World Cups between 2002 and 2014: a narrative review with a focus on NSAIDsThe use and abuse of painkillers in international soccer: data from 6 FIFA tournaments for female and youth players.Preventive Health Perspective in Sports Medicine: The Trend at the Use of Medications and Nutritional Supplements during 5 Years Period between 2003 and 2008 in FootballProphylactic use of NSAIDs by athletes: a risk/benefit assessment.Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans.Use and abuse of medication during 2014 FIFA World Cup Brazil: a retrospective survey.Oxidative stress and inflammation: liver responses and adaptations to acute and regular exercise.Ibuprofen before Exercise Does Not Prevent Cortical Bone Adaptations to Training.Medications and Nutritional Supplements in Athletes during the 2000, 2004, 2008, and 2012 FIFA Futsal World Cups.Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration.Determination of stanozolol and 3'-hydroxystanozolol in rat hair, urine and serum using liquid chromatography tandem mass spectrometry.The use of drugs and nutritional supplements in top-level track and field athletes.Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis.Inhibitory Effects of Diclofenac on Steroid Glucuronidation In Vivo Do Not Affect Hair-Based Doping Tests for Stanozolol.Use of Non-Steroidal Anti-Inflammatory Drugs among Participants in a Mountain Ultramarathon Event.Anti-doping for Paralympians
P2860
Q28082804-0EEC8F53-682E-4311-A012-62B11F67E994Q33375323-6D89BDF1-A4D6-4DDF-A0D1-9B6C6F507ADFQ33974462-8EB13400-3254-4113-9356-7F9C9D55829EQ34112547-26B03B8C-C432-49D0-8098-4D452302AF64Q34146722-534F4C7D-40C1-4BFD-9943-3983721F58B1Q36053728-6525E8AC-E854-4B33-8687-2A491FA8606AQ38976134-B31F8F24-EE63-4219-88CC-67053AD69E95Q39024997-3C18AB5A-9096-4F3C-9189-6EC7876E65AAQ40313329-0B277BB0-9362-4D40-B3E7-817159F15339Q41624660-2DEC7441-9792-4272-B4A5-8905E8230A38Q42060254-2C306C72-6717-4B03-BDB1-9B22071482F7Q43265363-A6404750-1D27-48BF-8DA1-C3323DC0D66CQ47983804-3D815E51-8920-431D-A34B-3EC7992F1115Q52860574-5AFEDBF9-E9E5-40EB-8D75-2F13B19F03FBQ55176205-F79FE07B-00D8-4502-BF72-0B2F4281B546Q58178785-8982B04A-98AC-40B0-AC41-36E232121EC5
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Declared use of medication in sports.
@en
Declared use of medication in sports.
@nl
type
label
Declared use of medication in sports.
@en
Declared use of medication in sports.
@nl
prefLabel
Declared use of medication in sports.
@en
Declared use of medication in sports.
@nl
P1476
Declared use of medication in sports.
@en
P2093
Frans T Delbeke
Wim Van Thuyne
P304
P356
10.1097/JSM.0B013E318163F220
P577
2008-03-01T00:00:00Z